跳至主要内容
临床试验/NCT01761552
NCT01761552Unknown4 期

A Prospective, Randomized Controlled Trial Comparing Traditional Methods of Neuromuscular Block Reversal to Sugammadex for Extubation in the Operating Room in ASA 4 and 4E Patients.

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
130
试验地点
1
主要终点
Extubation in the operating room before transfer to the PACU or ICU versus keeping the patient intubated when transferred.

研究概览

简要总结

To demonstrate that the use of Sugammadex enables physicians to perform early extubation in the operating room in ASA 4 & 4E patients

Primary endpoint:

• Extubation in the operating room before transfer to the PACU or ICU versus keeping the patient intubated when transferred.

Secondary endpoints:

• Time to extubation - measure the difference in time from application of the surgical dressing until extubation. Atelectasis - comparison of chest x-rays (CXR): prior to surgery, on admission to PACU or ICU and 24 hours after admission to PACU or ICU (This is the routine practice at Hadassa hospital for ASA IV patients.)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA 4 AND ASA 4E patients
  • Patients scheduled to undergo any bowel, urogenital or orthopedic surgery under general anesthesia where use of neuromuscular blocking agents is indicated. -

排除标准

  • Patients ASA 1-3 or 5
  • Patients who have a medical condition which precludes extubation at the end of surgery (i.e., mesenteric event, severe hypothermia etc.).
  • Presence of an advanced directive to withhold or withdraw life sustaining treatment (i.e. DNR).
  • Hypersensitivity to the active substances or to any of the excipients of medications used
  • Patients with severe renal impairment (including patients requiring dialysis (CrCl < 30mL/min))
  • Patients with severe hepatic impairment
  • Age < 18 years

研究组 & 干预措施

Sugammadex (tradename Bridion)

Experimental

干预措施: Sugammadex Reversal (Drug)

Traditional reversal or spontaneous recovery:

Active Comparator

Atropine/Neostigmine: Atropine, 0.02 mg/ kg, and Neostigmine,0.05 mg/kg diluted in 100 ml Normal Saline and given over a 10 min drip. Reversal will be given only recommended if spontaneous recovery has occurred up to the reappearance of T2 (shallow blockade) following rocuronium induced blockade.

干预措施: Atropine/Neostigmine (Drug)

结局指标

主要结局

Extubation in the operating room before transfer to the PACU or ICU versus keeping the patient intubated when transferred.

时间窗: 24 hours

次要结局

  • Time to extubation - measure the difference in time from application of the surgical dressing until extubation.(24 hours)
  • Atelectasis - comparison of chest x-rays (CXR): prior to surgery, on admission to PACU or ICU and 24 hours after admission to PACU or ICU (This is the routine practice at Hadassa hospital for ASA IV patients.)(24 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Prospective, Randomized Controlled Trial Comparing... | 临床试验